Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Neurological Medicine
Volume 2013, Article ID 630141, 4 pages
http://dx.doi.org/10.1155/2013/630141
Case Report

Diagnosing Sporadic Creutzfeldt-Jakob Disease in a Patient with a Suspected Status Epilepticus in the Intensive Care Unit

1University Medical Centre Groningen, GN, The Netherlands
2Department of Intensive Care, The Medical Centre Leeuwarden, FR Leeuwarden, The Netherlands
3Department of Neurology, The Medical Centre Leeuwarden, FR Leeuwarden, The Netherlands

Received 14 February 2013; Accepted 20 March 2013

Academic Editors: F. C. Henderson, M. Kurz, and J. Lazareff

Copyright © 2013 Harm J. van der Horn et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. G. Wieser, K. Schindler, and D. Zumsteg, “EEG in Creutzfeldt-Jakob disease,” Clinical Neurophysiology, vol. 117, no. 5, pp. 935–951, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Jacobi, S. Arlt, H. Reiber et al., “Immunoglobulins and virus-specific antibodies in patients with Creutzfeldt-Jakob disease,” Acta Neurologica Scandinavica, vol. 111, no. 3, pp. 185–190, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. I. Zerr, M. Pocchiari, S. Collins et al., “Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease,” Neurology, vol. 55, no. 6, pp. 811–815, 2000. View at Google Scholar · View at Scopus
  4. A. W. Lemstra, M. T. Van Meegen, J. P. Vreyling et al., “14-3-3 testing in diagnosing Creutzfeldt-Jakob disease: a prospective study in 112 patients,” Neurology, vol. 55, no. 4, pp. 514–516, 2000. View at Google Scholar · View at Scopus
  5. P. Sanchez-Juan, A. Green, A. Ladogana et al., “CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease,” Neurology, vol. 67, no. 4, pp. 637–643, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Schrooten, W. de Vooght, S. Weckhuysen, W. van Paesschen, and P. van Damme, “Normalization of 14-3-3 in CJD,” Acta Neurologica Belgica, vol. 108, no. 2, pp. 64–66, 2008. View at Google Scholar · View at Scopus
  7. C. Hamlin, G. Puoti, S. Berri et al., “A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease,” Neurology, vol. 79, pp. 547–552, 2012. View at Google Scholar
  8. K. Satoh, S. Shirabe, A. Tsujino et al., “Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease,” Dementia and Geriatric Cognitive Disorders, vol. 24, no. 3, pp. 207–212, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Aiguabella, M. Falip, M. Veciana et al., “Refractory nonconvulsive status epilepticus in Creutzfeldt-Jakob disease,” Epileptic Disorders, vol. 12, no. 3, pp. 239–242, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Lapergue, S. Demeret, V. Denys et al., “Sporadic Creutzfeldt-Jakob disease mimicking nonconvulsive status epilepticus,” Neurology, vol. 74, no. 24, pp. 1995–1999, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Foreman, J. Claassen, K. Abou Khaled et al., “Generalized periodic discharges in the critically ill: a case-control study of 200 patients,” Neurology, vol. 79, pp. 1951–1960, 2012. View at Google Scholar
  12. I. Zerr, K. Kallenberg, D. M. Summers et al., “Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease,” Brain, vol. 132, no. 10, pp. 2659–2668, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. G. S. Young, M. D. Geschwind, N. J. Fischbein et al., “Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis,” American Journal of Neuroradiology, vol. 26, no. 6, pp. 1551–1562, 2005. View at Google Scholar · View at Scopus
  14. Y. Shiga, K. Miyazawa, S. Sato et al., “Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease,” Neurology, vol. 63, no. 3, pp. 443–449, 2004. View at Google Scholar · View at Scopus
  15. M. D. Geschwind, C. A. Potter, M. Sattavat et al., “Correlating DWI MRI with pathologic and other features of Jakob-Creutzfeldt disease,” Alzheimer Disease and Associated Disorders, vol. 23, no. 1, pp. 82–87, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. B. van Everbroeck, I. Dobbeleir, M. de Waele, P. de Deyn, J. J. Martin, and P. Cras, “Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients,” Journal of Neurology, vol. 251, no. 3, pp. 298–304, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. U. Heinemann, A. Krasnianski, B. Meissner et al., “Brain biopsy in patients with suspected Creutzfeldt-Jakob disease: clinical article,” Journal of Neurosurgery, vol. 109, no. 4, pp. 735–741, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Jansen, M. Schuur, W. G. Spliet, W. A. van Gool, C. M. van Duijn, and A. J. Rozemuller, “Eleven years of autopsy on account of Creutzfeldt-Jakob disease in the Netherlands,” Nederlands Tijdschrift voor Geneeskunde, vol. 153, article A172, 2009. View at Google Scholar · View at Scopus
  19. K. Murray, “Creutzfeldt-Jacob disease mimics, or how to sort out the subacute encephalopathy patient,” Practical Neurology, vol. 11, no. 1, pp. 19–28, 2011. View at Google Scholar · View at Scopus